 |
|
|
|
|
|
|
| Article 1 to 7 out of 7 concerning Abbott Laboratories
|
-
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
(11 Mar 2008)
Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer
Abbott announced that its molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals, Inc. to develop a gene test to potentially assess the clinical benefit of Tarceva(R) ...
-
OncoMethylome Sciences to Profile DNA for Abbott Oncology Compounds
(18 Dec 2007)
OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation ...
-
Innogenetics receives unanimous verdict against Abbott
(05 Sep 2006)
On Friday, September 1, 2006, a Jury unanimously upheld the validity of Innogenetics' patent, U.S. Patent No. 5,846,704 ("the '704 patent"), which claims a method of genotyping the Hepatitis C Virus ("HCV"). The dispute began in September 2005 when ...
-
New Real-Time PCR Test for Chlamydia and Gonorrhea Receives CE Mark Certification
(25 Jan 2006)
Abbott announced that a highly sensitive new test for the simultaneous detection of the sexually transmitted pathogens Chlamydia trachomatis (CT) and Neissera gonorrhoeae (NG) has received CE Mark certification, allowing it to be marketed in the ...
-
Celera Genomics Acquires Full Ownership of Celera Diagnostics Joint Venture
(11 Jan 2006)
Celera Genomics to Partner or Sell Small Molecule Drug Development Programs
Applera Corporation announced that its Board of Directors has approved a restructuring of its Celera Diagnostics joint venture, whereby, effective January 1, 2006, Celera Genomics acquired Applied Biosystems' 50 percent interest in the joint venture ...
-
Celera Genomics and Abbott Announce Target Selection from Research Collaboration
(19 Apr 2005)
Celera Genomics Group, an Applera Corporation business, and Abbott announced that two Celera antigen targets have been selected for further investigation by Abbott for therapeutic development. These are the first targets to be selected for ...
-
Abbott enters into agreement with Inpeco to expand laboratory automation capabilites
(04 Mar 2005)
Abbott announced that it has entered into an agreement with Inpeco S.p.A. to expand its laboratory automation capabilities. Through the agreement, Abbott plans to offer a suite of automation solutions that can be customized to address key needs ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon